In vertebrates, the neurulation proceeds by two distinct processes, primary neurulation (PN) and secondary neurulation (SN), which construct the neural tube in the anterior and posterior regions of the body, respectively. We have been studying how the SN process is regulated using chicken embryos, in which PN switches to SN around at the hind limb bud level. During SN, undifferentiated mesenchymal precursors undergo mesenchymal-to-epithelial transition (MET). When EGFP-labeled SN-precursors are orthotopically transplanted to a non-labeled host embryo, these cells are found both in the neural tube and undifferentiated mesenchymal population, suggesting that SN-precursors contain stem cell-like population. To investigate into more details, we divided a mass of SN-precursors into the posterior-and anterior halves, and used each of them for the transplantation. The anterior half participated in the neural tube formation, but did not stay as undifferentiated. In contrast, cells of the posterior half were found in both the neural tube and undifferentiated population in the host. Such distinct behaviors between the anterior-and posterior halves appear to be caused by differential levels of the transcription factor Sox 2. We propose a model that high-level Sox2 drives cells into epithelial differentiation, whereas low-level Sox2 is for the maintenance of the undifferentiated state of SN stem-like cells. We will discuss how the Sox2-dependent cell differentiation is coordinated with MET during SN.
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di processes aroundWhen EGFP-labeled SNprecursors orthotopically transplanted to non-labeled. Ageing is a complicated process which causes gradual loss of function in tissues and organs. As ageing proceeds, the incidence of chronic diseases rises in individuals. Recent evidence shows placental tissues undergo significant molecular age-related changes in a short period, between early-term (37 0/7-38 6/7 weeks gestation) to late/post-term (41 0/7 weeks gestation and beyond), after the due date of the pregnancy has been reached. Moreover, there is a dramatic increase in the risk of unexplained antepartum stillbirths in pregnancies that progress into the late/post-term period, which may be linked to increased ageing of placenta. Mesenchymal stem cells (MSCs) play an important role in embryogenesis and in the formation of the placenta. However, the role and contribution of MSCs to the ageing processes in the feto-maternal interface during the period from early-term to late/post-term is unknown. The objective of this study was to compare stem cell properties, and ageing/senescence functions of early-term and late/ post-term MSCs isolated from the maternal decidua.
Isolated DMSCs showed the expected characteristics and properties of this cell type. There was a significant increase in HMGB1 expression in late/post-term DMSCs compared with early-term DMSCs (n= 6 each group, p-value b0.05). The level of cell apoptosis was significantly higher in late/post-term DMSCs compared with early-term DMSCs (n= 6 each group, p-value b0.01). Using a quantitative Aldeflour assay, early-term DMSCs showed a significantly higher resistance to oxidative stress compared with late/postterm DMSCs (n =6 each group, p-valueb0.01). The total antioxidant level was significantly higher in late/post term DMSCs compared with early-term DMSCs (n =6 each group, p-valueb0.05). These data provide the first evidence of advanced ageing and loss of important stem cell functions in late/post-term DMSCs. Future studies will employ whole genome array comparisons to determine the specific biological pathways, and regulatory molecules, involved in the advanced ageing of late/post-tem DMSCs. The Aorta Gonad Mesonephros hereafter designated as the AGM is an intraembryonic site shown to be able to generate the first adult type hematopoietic stem cells (HSC) autonomously. HSC emerge from a specific subset of endothelial cells designated as hemogenic via an endothelial to hematopoietic transition that takes place in the ventral aspect of the aorta. Despite intense investigations, few is known about the mechanisms regulating this process. It has been shown recently that sympathetic signalling was controlling HSC homeostasis in the bone marrow niche and that the tyrosine hydroxylase-signalling pathway was playing a role in HSC generation in the mouse AGM. Here we have analysed the role of the neural crest cells in the emergence and maturation of Hematopoietic Stem Progenitor Cells (HSPCs) in the avian embryo aorta using ablation of neural crest cells and using agonists and antagonists of the tyrosine hydroxylase on in vitro aorta liquid cultures. We show that neural crest cell ablation has a profound effect on the formation of aortic hematopoiesis leading to a loss of hematopoietic clusters and a loss of runx1 expression in the aortic floor. Moreover inhibiting the tyrosine hydroxylase signalling pathway results in a profound decrease of CD45 + c-kit+ hematopoietic cells. Taken together, these findings indicate that neural crests cells and the catecholamine signalling pathway play a key role in aortic hematopoiesis and demonstrate that the recently described functional interplay between the hematopoietic system and the SNS shown on the bone marrow and the early mouse embryo also extends to the earliest stages of their co development in birds. To obtain an insight into the transcription factor (TF)-dependent regulation of epiblast stem cells (EpiSCs), we performed ChIP-seq analysis of the genomic binding sites in EpiSCs of five major TFs, ZIC2, OTX2, SOX2, POU5F1, and POU3F1, using biotinylated TFs, identifying the following new features: (1) The genomic domains of megabase scale rich in ZIC2 peaks and genes, and those rich in POU3F1 but sparse in genes, alternate in EpiSCs, reflecting the clustering of regulatory regions that act in short-and long-ranges, which involve binding of ZIC2 and POU3F1, respectively. (2) Mouse embryonic stem cells (ESCs) are established from the inner cell mass (ICM) of lastocyst and sustains pluripotent state. In contrast, ICM loses pluripotency gradually along the development in vivo. These results strongly suggest that some molecular events should take place to capture the sustainable pluripotency of ESCs. We tried to reveal the molecular mechanism underling the establishment of sustainable pluripotency of ESCs.
First, we confirmed that pluripotent state could be maintained under the serum-free medium containing only low concentration of GSK3 inhibitor and LIF (LowGiL condition). The ESCs cultured under the LowGiL condition, hereafter LowGiL-ESCs, expressed pluripotent markers and contributed to chimeric embryos, including germ cells at comparable levels to the ESCs cultured under the 2iL condition (2iL-ESCs). However, LowGiL condition was insufficient to establish ESCs, which was due to the spontaneous differentiation during the culture. Although there was not significant difference in colony morphology, the expression levels of pluripotent markers (Nanog, Oct4 and Sox2) were significantly decreased in the LowGiL condition than that in the 2iL condition at day 7 of culture. Meanwhile, culture of blastocyst cells during the first 3 days under the 2iL condition brought about the pluripotent state and subsequent stable pluripotency even under the LowGiL condition. Transcriptome analysis of ICM and 3-dayscultured ICM under the 2iL condition revealed the significant upregulation of the pluripotent markers, including Sox2 and Nr0b1. Considering that up-regulation of these genes was not observed with the LowGiL-condition, it is quite likely that these activations are the molecular basis of the induction of sustainable pluripotency. Pharmaceuticals and chemicals are primarily metabolized in the liver. Drug-induced liver injury (DILI) remains a leading cause of new drug withdrawal from human clinical trials. Therefore, a hepatic platform mimicking liver physiology is perceived for drug development. Hepatocytes differentiated from human embryonic stem cells (ESCs) or human induced pluripotent stem cells (iPSCs) are expected to be useful for the prediction of DILI in drug development. However, the actual applicability is hampered by the limited availability of metabolically functioning hepatocytes derived from human pluripotent stem cells (PSCs). In order to generate hepatocytes expressing drug-metabolizing enzymes from PSCs that would be applicable for drug hepatotoxicity testing, the current work tried to enhance metabolic function of ESC-derived hepatocytes via employing microRNAs differentially expressed in primary human hepatocytes. We initially setup protocols to differentiate human ESCs and iPSCs to hepatocyte-like cells. MicroRNA expression profiling and real-time quantitative PCR analysis were then conducted in PSC-derived hepatocyte-like cells and primary human hepatocytes. 24 miRNAs we found to express at high levels in primary hepatocytes compared to PSC-derived hepatocyte-like cells. We validated expression of seven miRNAs including hsa-miR-664a-3p, hsa-miR-194-3p, hsamiR-29c-5p, hsa-miR-4662a-5p, hsa-miR-885-5p, hsa-miR-126-5p, hsa-miR-122-3p and found transfection of hsa-miR-194-3p, hsamiR-126-5p, and hsa-miR-122-3p can significantly enhance the expression levels of the metabolizing enzymes such as CYP1A2, CYP2C9, UGT1A9, UGT2B4, and promote these enzymes activity in both HepG2/C3A cells and PSC-derived hepatocyte-like cells. Hopefully, the findings from the current work can lead to develop a strategy that can enhance metabolic function of PSC-derived hepatocyte-like cells. And these PSC-derived hepatocyte-like cells can be used for the prediction of DILI in drug development in the near future. Stem cells require different type of supporting cells, niches, to control their maintenance and differentiation; however, little is known about how those niches are formed. Here, we report that in the development of the Drosophila ovary the anterior-posterior Hedgehog (Hh) signaling gradient sets differential cell affinity for somatic gonadal cells (SGPs) to architect the ovary and specify intermingled cells (ICs), which contribute to both germline stem cell (GSC) maintenance and differentiation niches, thus maintaining GSC homeostasis throughout life. Terminal filaments, stacks of disc-shaped cells, locate anteriorly of the gonad and produce Hh. Hh-receiving SGPs posterior to terminal filaments express low-level E-cadherin, adapt stromal IC fate and intermingle with PGCs. In contrast, SGPs away from terminal filaments with weak Hh signaling
